Proterris
Manufacturing · Portugal · 1-10 Employees
View Company Info for Free
Overview
Headquarters
PortugalWebsite
www.proterris.comRevenue
<$5 MillionIndustry
About Proterris
Proterris is a biotechnology company focused on the therapeutic uses of carbon monoxide (CO) to address unmet needs in solid organ transplantation. Co-founded by Apeiron Partners, LLC and several prestigious universities, the company has developed a range of inhaled and small molecule CO therapeutics targeting transplant, nephrology, pulmonary, and oncology applications. With a strong intellectual property position and a pipeline supported by significant funding, Proterris aims to serve a patient population of over 20 million in the U.S. alone. The team consists of experienced professionals in clinical leadership and company development.Explore more
SIC Code 28,283NAICS Code 32,325Show moreProterris Org Chart
Compare Similar Companies to Proterris
Compare insights from companies similar to Proterris, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Proterris Tech Stack
A closer look at the technologies used by Proterris
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Proterris
Sign Up For FreeTo access detailed company insights
Proterris is a biotechnology company focused on the therapeutic uses of carbon monoxide (CO) to address unmet needs in solid organ transplantation. Co-founded by Apeiron Partners, LLC and several prestigious universities, the company has developed a range of inhaled and small molecule CO therapeutics targeting transplant, nephrology, pulmonary, and... Read More